H. R. 2182
IN THE HOUSE OF REPRESENTATIVES
March 23, 2021
Ms. Wexton (for herself, Mr. Beyer, Mr. Casten, Mr. Foster, Mr. Meeks, Mr. Raskin, and Mrs. Trahan) introduced the following bill; which was referred to the Committee on Science, Space, and Technology
To conduct a study on the spread of COVID–19-related disinformation and misinformation on the internet and social media platforms, and for other purposes.
This Act may be cited as the
COVID–19 Disinformation Research and Reporting Act of 2021.
Congress finds the following:
The National Academies of Sciences, Engineering, and Medicine and the National Science Foundation have provided scientific, evidence-based findings and foundational research, across all disciplines, that benefit the people of the United States.
Accurate and reliable information is imperative for health and safety during a national emergency like the COVID–19 pandemic.
Disinformation and misinformation have spread alarmingly during the COVID–19 pandemic, hindering the public response efforts of Federal, State, local, and indigenous leaders.
The internet and social media have made it easier to spread fake medical information, such as unproven treatments for COVID–19, or inaccurate information that undermines scientific experts.
The internet and social media have likewise made it easier to spread disinformation and misinformation about the safety and efficacy of COVID–19 vaccines, impacting public acceptance of the vaccines and threatening to prolong the pandemic.
COVID–19-related disinformation has been weaponized by foreign adversaries, including Russia, China, and Iran, through the use of fake social media accounts and bot networks to amplify content.
Understanding the financial incentives for entities spreading and amplifying disinformation and misinformation can help to combat its distribution.
Science study on COVID–19-related disinformation and misinformation
Not later than 30 days after the date of enactment of this Act, the Director of the National Science Foundation shall enter into an arrangement with the National Academies of Sciences, Engineering, and Medicine to conduct a study on the current understanding of the spread of COVID–19-related disinformation and misinformation on the internet and social media platforms. The study shall address—
the roles disinformation and misinformation have played in the public response to COVID–19, including public acceptance of and demand for COVID–19 vaccines;
the sources, both foreign and domestic, of COVID–19-related disinformation and misinformation, and the mechanisms by which that disinformation and misinformation influence the public debate;
the role social media plays in the dissemination and promotion of COVID–19-related disinformation and misinformation content and the role social media platforms play in the organization of groups seeking to spread COVID–19-related disinformation and misinformation;
the potential financial returns for creators or distributors of COVID–19-related disinformation and misinformation and the role such financial incentives play in the propagation of COVID–19-related disinformation and misinformation;
potential strategies to mitigate the dissemination and negative impacts of COVID–19-related disinformation and misinformation (and specifically the dissemination of disinformation and misinformation on social media), including through improved disclosures and addressing information literacy; and
an analysis of—
the limitations of the mitigation strategies described in paragraph (5); and
how the strategies can be implemented without infringing on the constitutional rights and civil liberties of the people of the United States.
In entering into an arrangement under this section, the Director of the National Science Foundation shall request that the National Academies of Sciences, Engineering, and Medicine transmit to Congress a report on the results of the study not later than 1 year after the date of enactment of this Act.
There is authorized to be appropriated, for the purposes of conducting the study under this section, $1,000,000.